Previous studies have shown that point mutations in the eector domain of Rac1 block speci®c downstream pathways such as PAK, JNK/SAPK kinases and membrane ruing. Speci®cally, the F37A mutation, made in a constitutively activated Q61L background, activates PAK but fails to induce membrane rues. We now show that Q61L/F37A Rac not only fails to induce ruing but potently blocks membrane ruing induced by serum or PDGF. In the presence of serum, cells do extend ®lopodia, suggesting that this mutant only blocks a subset of the eectors that induce cytoskeletal reorganization. At later times, this rac mutant induces membrane blebbing, but not apoptosis. These results show that Q61L/F37A Rac, is constitutively activated with respect to PAK activation but functions as a dominant negative for another pathway, membrane ruing. That an eector domain point mutant can simultaneously function as a dominant negative and dominant positive for dierent pathways implies that eects of these variants on cell functions must be interpreted with caution.
Introduction
The Rho family of small GTP binding proteins regulates organization of the actin cytoskeleton, gene expression, cell cycle progression and membrane transport (reviewed in Ridley, 1996; Nobes and Hall, 1994) . Rac1 and Rac2 control formation of membrane rues in ®broblasts and play important roles in cell growth and motility. Rac also mediates activation of the p38 kinase and jun C-terminal kinase (JNK/SAPK) pathways in these cells (Coso et al., 1995; Minden et al., 1995; Bagrodia et al., 1995; Zhang et al., 1995) .
Rac and its close relative cdc42 appear to have a number of putative eectors, including the 65 kD protein kinase PAK (Manser et al., 1994) . One group of eectors, which includes PAK, share a region of sequence homology named the CRIB motif that mediates binding to Rac and cdc42 (Burbelo et al., 1995) . These proteins bind to an N-terminal eector domain in Rac and cdc42 spanning approximately residues 25 ± 45, similar to other Ras family members.
Recent reports have analysed Rac and cdc42 variants that contain point mutations in their Nterminal eector domains (Westwick et al., 1997; Lamarche et al., 1996) . Point mutants were constructed in V12 or Q61L backgrounds to give constitutively activated proteins that would show dominant positive eects. These studies of Rac point mutations revealed that induction of membrane ruing and cell cycle progression were independent of activation of PAK and other CRIB domain proteins, and activation of the JNK/SAPK pathway (Westwick et al., 1997; Lamarche et al., 1996) .
One of these mutations, Q61L/F37A, was found to abolish induction of membrane ruing and DNA synthesis but did not aect PAK or JNK/SAPK activation (Lamarche et al., 1996) . While studying this mutant in NIH3T3 cells, we made the observation that its expression caused loss of membrane rues. Further analysis showed that despite the presence of a mutation to inhibit the GTPase and cause constitutive activation, this variant not only fails to induce membrane ruing but acts as a dominant negative for this pathway. These data indicate that cellular responses to Rac eector domain point mutations may be more complex than previously thought.
Results

Loss of membrane rues
A Rac1 variant containing the F37A mutation in a Q61L background was expressed in NIH3T3 cells by injecting expression vector cDNA into cell nuclei. Protein expression was monitored either by staining ®xed cells with an antibody to the myc epitope tag or by co-injection of a cDNA vector for green¯uorescent protein (GFP). Protein was detectable within 1 h of injection, and eects on cell morphology were readily observable by 2 h.
As previously described (Westwick et al., 1997; Lamarche et al., 1996) , expression of Q61L/F37A Rac in serum starved NIH3T3 cells had little or no eect on morphology or cytoskeletal organization ( Figure 1a ). By contrast, wild type (but activated) Rac (Q61L Rac) induced extensive membrane ruing (Figure 1a) , as did the Q61L/Y40C mutant (not shown). In the presence of 10% serum, approximately 80% of control NIH3T3 cells showed signi®cant, sometimes extensive membrane ruing (Figure 1b) . By 3 h after injection of DNA for Q61L/F37A Rac, rues collapsed and cell spreading was slightly decreased. DNA for GFP alone or other control constructs including wild type Rac, Y40C/Q61L Rac and PAK did not cause similar changes (not shown). Quantitation of results showed that the percentage of cells exhibiting membrane rues decreased from 79+3% to 10+2% (n=3). Even in the low percentage of Q61L/F37A Rac-expressing cells that continued to show some membrane ruing, the extent of ruing was substantially decreased. Additional experiments con®rmed that expression of Rac Q61L/F37A induced PAK activation in these cells (GM Bokoch, unpublished data) , as report (Lamarche et al., 1996; Westwick et al., 1997) .
Cells expressing Q61L/F37A Rac showed thin processes that resembled ®lopodia or retraction ®bers. Staining with rhodamine-phalloidin revealed that these extensions contained actin (Figure 1b) . To determine whether these processes were ®lopodia or retraction ®bers, cell morphology was analysed by time lapse photography. Figure 2 shows that a cell expressing Q61L/F37A Rac contained retraction ®bers but clearly extended ®lopodia from another region of the cell.
These ®lopodia were observed to translocate and to disappear while other ®lopodia formed. Time lapse analysis of cells expressing Q61L/F37A Rac showed that 11 out of 11 showed formation, growth and movement of ®lopodia. Time lapse analysis of cells expressing Q61L/F37A Rac in low serum showed a drastic reduction in ®lopodia formation (not shown).
For comparison, the Rac N17 mutant was examined. This mutant had no discernible eect on cell morphology or cytoskeletal organization in serum starved cells (Figure 1a ). When expressed in cells in 10% serum, it also induced loss of membrane rues and lamellipodia ( Figure 1b ). In many cases, similar actin-rich thin processes were seen in ®xed cells. Processes induced by N17 Rac were generally less dramatic, however. Furthermore, time lapse analysis showed little or no formation or growth of ®lopodia (not shown); only one out of 12 cells examined showed growth of ®lopodia. Thus, Q61L/F37A Rac causes loss of membrane rues but the cellular responses are distinct from N17 Rac.
Blebbing
At later times after expression of Q61L/F37A Rac in NIH3T3 cells, membrane blebbing was apparent. By 7 h after injection, more than 50% of injected cells had extensive blebbing (Figure 3a ). This eect was observed only at higher doses of DNA: concentrations below 50 ng/ml were highly eective at inducing loss of membrane rues and formation of ®lopodia but did not trigger bleb formation, whereas 100 ng/ml or higher triggered blebbing in the majority of injected cells. Rhodamine-phalloidin staining showed that these membrane blebs had signi®cant F-actin around their periphery (not shown). Even extensively blebbed cells, however, retained actin stress ®bers (Figure 3a) , suggesting that cells were not undergoing apoptosis. Indeed, staining these cells for fragmented DNA using the TUNEL assay revealed no speci®c staining ( Figure  3b ). In addition, the nuclei remained intact, unlike those of apoptotic cells where chromatin condenses and the nuclei fragment. After 24 h, blebbing was noticeably diminished, but even cells that still blebbed remained viable and showed no signs of nuclear condensation (Figure 3a) . To con®rm that apoptotic cells were not lost during the extended incubation, cells were injected with a mixture of Q61L/F37A Rac DNA (200 ng/ml) plus DNA coding for GFP (20 ng/ml). The number of¯uorescent cells was scored at 4 ± 6 h after injection and then again at 24 h. The total number of uorescent cells in two experiments increased from 49 ± 55 (10+14% increase). This increase is most likely due to cell division. Taken together, these results indicate that membrane blebs induced by Q61L/F37A are not due to apoptosis.
Cell growth
Rac has also been found to play a role in cell cycle progression (Olson et al., 1995) . The Q61L/F37A mutant did not induce DNA synthesis in starved cells (Lamarche et al., 1996; Westwick et al., 1997) , but eects in growing cells were not examined. To determine whether dominant negative eects on DNA synthesis occur, cells in 10% serum were injected with cDNA for Q61L/F37A Rac at 50 ng/ml, a concentration that eciently blocks ruing but does not induce blebbing. As a control, wild type Q61L Rac was also examined. Eight hours after injections, BdUr was added to the medium to label cells in S phase. They were ®xed after 16 h of labeling and stained for both the myc epitope tag to detect expressing cells and with an antibody to BdUr. The level of DNA synthesis in Q61L/F37A Rac-expressing cells was slightly lower than uninjected cells but was similar to cells expressing wild type Q61L Rac (Table 1) . It should be noted, however, that higher doses of DNA that induce blebbing do appear to inhibit replication. Cells expressing GFP alone showed an increase in cell number over 16 h of 51+14% (n=2), compared to 10+14% for cells expressing Q61L/F37A Rac. Injection of control cDNA's (GFP or empty vector) did not inhibit cell growth (not shown). These results suggest that membrane blebbing or other eects of high doses of Q61L/F37A Rac DNA are growth inhibitory, but these eects are most likely indirect.
Swiss 3T3 cells
Because many studies of Rac and its mutants have been carried out in Swiss 3T3 cells, we also examined the eects of Q61L/F37A in this system. Swiss 3T3 cells were maintained in serum-free medium for 24 h, then were injected with Rac cDNA. After 3.5 h, cells were treated with PDGF to induce membrane ruing. Uninjected cells without PDGF show no ruing (Figure 4) . Most cells had a band of actin staining parallel to the edges, but some cells also had perpendicular ®lament bundles that formed short projections. Upon addition of PDGF, cells showed extensive ruing as expected (Figure 4 ). Cells expressing Q61L/F37A Rac in the absence of PDGF tended to have more perpendicular ®lament bundles leading to the edge of the cell; in higher expressors, there also appeared to be some increase in poorly organized actin ®laments throughout the cell, though this eect was not dramatic. Upon addition of PDGF, Q61L/F37A Rac-expressing cells showed virtually no induction of rues. Quantitation of these results showed that ruing was reduced from 79+4% for uninjected cells to 8+7% (n=4) for cells expressing Q61L/F37A Rac; a control in which cells were injected with empty vector plus GFP DNA showed 80+4% ruing after treatment with PDGF. Thus, Q61L/F37A Rac speci®cally blocked PDGF-induced ruing in Swiss 3T3 cells. High doses of Q61L/F37A Rac DNA did not induce membrane blebbing at later times in Swiss 3T3 cells.
Discussion
The major conclusion from these studies is that an activated (Q61L) variant of Rac1 containing the F37A point mutation inhibits serum-or PDGF-induced membrane ruing in NIH3T3 and Swiss 3T3 cells. This variant therefore not only fails to induce ruing but functions as a dominant negative in this regard. Additional eects on the cytoskeleton and/or membrane dynamics were also observed, speci®cally membrane blebbing and increased formation of structures that resemble ®lopodia. Membrane blebbing clearly was not due to apoptosis, since cells showed no signs of DNA fragmentation or nuclear condensation and survived. In other systems, blebbing can be induced by changes in membrane-cytoskeleton connections, or in cell volume regulation (Cunningham, 1995; Fedier and Keller, 1997; Myat et al., 1997) . These eects were entirely unrelated to apoptosis. Q61L/F37A Rac most likely perturbs one or both of these systems, but these eects are at present not understood.
Formation of ®lopodia in response to Q61L/F37A Rac was dependent on serum and was distinct from eects of N17 Rac. Membrane rues and lamellipodia contain bundles of actin ®laments that extend outward and that are connected by web-like regions, containing ®ne meshworks of micro®laments. The simplest explanation for the observed eects is that Q61L/ F37A Rac inhibits the formation of the connecting web regions but not the rod-like projections. Thus, structures similar to ®lopodia could still form and translocate. This could occur if Q61L/F37A Rac forms inactive complexes with a subset of Rac eectors, thereby blocking some of the eects of endogenous Rac. Q61L/F37A Rac also appears to induce weak but detectable actin polymerization or reorganization in starved Swiss 3T3 cells, indicating that it may have some dominant eects on the cytoskeleton. Such eects would be hard to detect in NIH3T3 cells since in low serum these cells retain a well organized cytoskeleton.
These results indicate that previous studies utilizing this mutant should be interpreted with caution. For example, the Q61L/F37A mutant may still associate with or activate some eectors of membrane ruing but downstream events would be blocked or masked by the dominant negative eects. Published work has shown that activation of PAK may mediate some eects of Rac or cdc42 on the cytoskeleton (Sells et al., 1997) . Q61L/F37A Rac activates PAK, but may simultaneously block subsequent PAK-induced cytoskeletal rearrangements. Clearly the behaviour of this Rac variant is unexpected and points towards a more complex mechanism of action than previously suspected. Furthermore, a number of studies have used point mutants of Rac and other Ras superfamily members to correlate eects on downstream eectors and cell functions such as growth, transformation or migration. The observation that an eector domain point mutant can activate one pathway but block another introduces a signi®cant complication into the interpretation of the results from such experiments.
Materials and methods
Reagents
Expression vectors for Rac and mutants thereof in pCMV1 were generously provided by Dr Alan Hall (University College, London). The GFP vector EGFP-C1 was a gift from Dr Sanford Shattil (Scripps Research Institute). PDGF-BB and other reagents were purchased from Sigma Chemicals (St Louis, MO).
Cells
NIH3T3 and Swiss 3T3 cells were grown in Dulbecco's Modi®ed Eagles Medium (DMEM) with 10% bovine calf serum. Swiss 3T3 cells were switched to serum-free DMEM 24 h before the experiment. They were treated with 25 ng/ ml PDGF for 10 min to induce ruing, then ®xed as described.
Injection and staining
Cells were injected into the nucleus with Rac DNAs at 0.2 mg/ml and GFP DNA was injected at 0.05 mg/ml unless otherwise noted. Cells were ®xed in 2% formaldehyde for 20 min and rinsed with phosphate-buered saline (PBS). Cells were permeabilized with 0.4% Triton X-100 in PBS for 2 min at room temperature. Expressed myc-tagged Rac protein was detected by staining with monoclonal anti-myc ascites diluted 1 : 300 in PBS with 10% normal goat serum for 45 min, followed by anity puri®ed FITC-anti-mouse IgG (Cappel, Durham, NC) at 1 : 200 under the same conditions. Actin was labeled with Rhodamine-phalloidin (Molecular Probes, Eugene, OR) at 1 : 100. For conventional microscopy, cells were photographed on a Nikon Diaphot¯uorescence microscope using a 406 oil immersion lens. For confocal microscopy, cells were examined using a BioRad 1024 laser scanning microscope with a 406 oil immersion lens.
Abbreviations GFP, green¯uorescent protein; PDGF, platelet derived growth factor; TUNEL, TdT-mediated UTP nick end labeling; JNK/SAPK, jun c-terminal kinase/stress activated protein kinase. Figure 4 Swiss 3T3 cells. Swiss 3T3 cells were kept 24 h in serum-free DMEM (control) then injected with DNA for GFP at 20 ng/ml plus Q61L/F37A Rac at 50 ng/ml or N17 Rac at 100 ng/ ml. After 4 h, some cells were stimulated with 25 mg/ml PDGF for 20 min as indicated. They were then ®xed with formaldehyde and stained. Expressing cells were detected by GFP¯uorescence and F-actin was visualized with rhodamine-phalloidin. Arrowheads denote the expressors where more than one cell is present. Membrane rues were induced in uninjected cells, but not in cells expressing Q61L/F37A or N17 Rac
